Amgen Data Breach Exposes Sensitive Information
Amgen Inc., a leading American biotechnology company, has announced that it experienced an unauthorized data breach in July 2026. The incident involved data stored in cloud environments hosted by third-party providers, prompting the company to activate its cybersecurity response plan and engage external forensic experts.
The affected information includes proprietary data, patient protected health information, and other sensitive information. Amgen is still assessing the full impact of the breach and is working with law enforcement and cybersecurity experts to determine the extent of the damage.
As a result of the breach, individuals whose information was exposed may be eligible for compensation, including reimbursement for out-of-pocket expenses, credit monitoring services, or damages related to identity theft or privacy violations. Those affected are advised to complete a form to join the lawsuit investigation and protect their rights.